Mantle Cell Lymphoma Insights

New Report Release: A Guide to Nutrition for Patients with Mantle Cell Lymphoma

Advertise with us

Exclusive Report

New Report Release: A Guide to Nutrition for Patients with Mantle Cell Lymphoma

We’re excited to share our latest in-depth report developed in collaboration with AllMyHealth. This guide provides practical insights on how nutrition plays a vital role in managing mantle cell lymphoma.

Key highlights: understanding mantle cell lymphoma and its impact on nutrition, general dietary guidelines for people with mantle cell lymphoma, specific nutritional needs for mantle cell lymphoma patients, practical advice and meal planning tips (including sample meal plans and recipes).

Available in both text and audio formats - dive in today and share with your community!

View the Full Report

The report is available for free online on the AllMyHealth website.

www.allmyhealth.io/reports

Report Thumbnail

Top Stories

Latest Research

In recent years, there has been significant progress in understanding and treating Mantle Cell Lymphoma (MCL), as highlighted by Armand (2025). The series of reviews introduced by Armand emphasizes advancements in patient risk stratification and novel therapies. One review focuses on the frontline management of MCL, pointing out the importance of ongoing phase 3 trials that are shaping the treatment landscape.

Another area of focus is the treatment of relapsed and refractory MCL, where new therapies are emerging. Additionally, the reviews address the importance of risk assignment in MCL patients, which now includes both clinical and molecular features. Lastly, the series delves into the biology of MCL, examining the disease's intrinsic vulnerabilities and the role of the tumor microenvironment, which could inform future research and patient care.

Community News

The Leukemia & Lymphoma SocietyThe Leukemia & Lymphoma SocietyFeb 14, 2025

The U.S. Food and Drug Administration has approved a new treatment for Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) that eliminates mealtime restrictions—making daily care simpler for newly diagnosed adults.

Find out more here 👉 https://bit.ly/3CUqZJP

Lymphoma ActionLymphoma ActionFeb 16, 2025

“A cancer nurse explained my diagnosis in more detail, along with the chemotherapy that I would receive. Nothing that was said actually sunk in with me though, as by this point I was in another universe! My advice for anyone in a similar situation is always to make sure you have someone with you to help digest the information.

I received my last round of chemo at the end of May 2021, and a PET scan followed in the July that showed I was in remission! I was told I would need to see my specialist regularly for monitoring, but from that point on I felt I could relax more in mind and body and make some future plans! My husband is my absolute hero, and I am so grateful to him and all the specialists and nurses who looked after me.

I am now four years on from receiving my diagnosis, and really enjoying life. I still get a little frustrated with myself and for my husband, as I am limited in certain ways now but as he reminds me, I am alive and we are doing what we can! The whole experience has taught me not to sweat the small stuff, and the importance of living for the moment. I hope my story will help others going through something similar.” Margaret

Margaret reflects on her treatment for diffuse large B-cell lymphoma 👉 www.lymphoma-action.org.uk/Margaret

#Lymphoma#BloodCancer#NonHodgkinsLymphoma

Lymphoma Action Post
Lymphoma Research FoundationLymphoma Research FoundationFeb 12, 2025

On February 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved brentuximab vedotin (Adcetris, Seagen Inc., a subsidiary of Pfizer) in combination with lenalidomide and a rituximab product for adult patients with relapsed or refractory large B-cell lymphoma (LBCL).

To learn more about this approval, visit us at: https://ow.ly/pq8b50UYUQn

Lymphoma Research Foundation Post

Upcoming Events

FEB
20
Whole Person Cancer Care Webinar Lymphoma Research Foundation • New York, NY    Online

Click Here to Join Our Community

Join Our Waitlist